VKTX241122C84000
- 0.25
- 0.000.00%
Viking Therapeutics Newsroom
Trump Nominates Marty Makary For FDA Commissioner
Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
How Is The Market Feeling About Viking Therapeutics?
Viking Therapeutics Analyst Ratings
B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109
Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
Viking Therapeutics Is More Than Just a Weight-loss Stock, and That's Drawing Cheers
Express News | Viking Therapeutics Shares Rise 4.6% Premarket After Co Presents Detailed Mid-Stage Data for Experimental Liver Disease Drug
Trending Stocks Today | Tonix Pharmaceuticals Surges 58.63% Post-Market
Viking Therapeutics Phase 2b Trial Into Non-Alcoholic Steatohepatitis Meets Primary, Secondary Endpoints
Express News | Viking Therapeutics Presents Results From Phase 2B Voyage Study of Vk2809 in Biopsy-Confirmed Nash/Mash at the 75TH Liver Meeting® 2024
Viking Therapeutics Presents Results From Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024
We're Interested To See How Viking Therapeutics (NASDAQ:VKTX) Uses Its Cash Hoard To Grow
3 Things You Need to Know If You Buy Viking Therapeutics Today
Is It Too Late to Buy Viking Therapeutics Stock?
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Express News | Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS
Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post
Trending Industry Today: Viking Therapeutics Leads Losses In Weight Loss Drugs Stocks